These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6325277)

  • 1. Glucocorticoids inhibit the growth of AtT-20 mouse pituitary tumor cells.
    Svec F
    Mol Cell Endocrinol; 1984 Apr; 35(1):33-40. PubMed ID: 6325277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between glucocorticoid biopotency and receptor binding in the AtT-20 cell.
    Svec F
    Endocrinology; 1984 Apr; 114(4):1250-8. PubMed ID: 6323138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of glucocorticoids with the AtT-20 cell: effect on protein accumulation.
    Svec F
    Arch Biochem Biophys; 1985 Jul; 240(1):184-90. PubMed ID: 2990343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of glucocorticoid receptor depletion and the suppression of ACTH secretion in the AtT-20 cell.
    Svec F
    J Steroid Biochem; 1984 Apr; 20(4A):821-7. PubMed ID: 6323880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation between the magnitude of nuclear binding and the biopotency of glucocorticoids.
    Svec F; Rudis M
    Endocrinology; 1982 Aug; 111(2):699-702. PubMed ID: 6284490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional identification of genes up- and down-regulated by glucocorticoids in AtT-20 pituitary cells using an enhancer trap.
    Harrison RW; Miller JC
    Endocrinology; 1996 Jul; 137(7):2758-65. PubMed ID: 8770895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of dexamethasone inhibition of adrenocorticotropin release in a mouse pituitary tumor cell line either by growing cells in the absence of dexamethasone or by addition of hypothalamic extract.
    Herbert E; Allen RG; Paquette TL
    Endocrinology; 1978 Jan; 102(1):218-26. PubMed ID: 217583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids regulate the glucocorticoid receptor in the AtT-20 cell.
    Svec F; Rudis M
    J Biol Chem; 1981 Jun; 256(12):5984-7. PubMed ID: 7240188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells.
    Watanabe H; Nicholson WE; Orth DN
    Endocrinology; 1973 Aug; 93(2):411-6. PubMed ID: 4352443
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoid negative feedback in sheep corticotrophs: a comparison with AtT-20 corticotroph tumor cells.
    Clark TP; Kemppainen RJ
    Am J Physiol; 1994 Aug; 267(2 Pt 2):R463-9. PubMed ID: 8067455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prepro-thyrotropin-releasing hormone 178-199 increases sensitivity of AtT-20 cells to dexamethasone.
    Revskoy S; Schwartz J; Redei E
    J Endocrinol; 2001 Dec; 171(3):491-8. PubMed ID: 11739015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation of the murine corticotropic tumour cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids.
    van Wijk PA; van Neck JW; Rijnberk A; Croughs RJ; Mol JA
    Mol Cell Endocrinol; 1995 Apr; 111(1):13-9. PubMed ID: 7544306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone-releasing factor releases ACTH from an AtT-20 mouse pituitary tumor cell line but not from normal pituitary cells.
    Nakane T; Tsai J; Audhya T; Brown C; Kardos P; Hollander CS
    Life Sci; 1987 Jun; 40(22):2161-7. PubMed ID: 2884543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Res; 1976 Dec; 36(12):4602-9. PubMed ID: 1000505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of steroid hormones on the level of corticotropin messenger RNA activity in cultured mouse-pituitary-tumor cells.
    Nakamura M; Nakanishi S; Sueoka S; Imura H; Numa S
    Eur J Biochem; 1978 May; 86(1):61-6. PubMed ID: 207519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary corticotrope tumor (AtT20) cells as a model system for the study of early inhibition by glucocorticoids.
    Woods MD; Shipston MJ; Mullens EL; Antoni FA
    Endocrinology; 1992 Dec; 131(6):2873-80. PubMed ID: 1332850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypoxia inducible factor-1α on apoptotic inhibition and glucocorticoid receptor downregulation by dexamethasone in AtT-20 cells.
    Zhang C; Qiang Q; Jiang Y; Hu L; Ding X; Lu Y; Hu G
    BMC Endocr Disord; 2015 May; 15():24. PubMed ID: 26002039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the AtT-20 cell's 'repleting' glucocorticoid receptor.
    Seigler L; Svec F
    Biochim Biophys Acta; 1984 Jul; 800(2):111-8. PubMed ID: 6331523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone stimulation of adrenocorticotropin production by mouse pituitary tumor cells in culture: possible model for anomalous release of adrenocorticotropin by thyrotropin-releasing hormone in some patients with Cushing's disease and Nelson's syndrome.
    Gershengorn MC; Arevalo CO; Geras E; Rebecchi MJ
    J Clin Invest; 1980 Jun; 65(6):1294-300. PubMed ID: 6251109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.